Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. TSLA
2. SPY
3. META
4. STZ
5. INTC
6. HOOD
7. FDS
8. FUTU
9. AMZN
10. MSFT

Go back to Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update

Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 4c

November 5, 2020 9:13 AM EST

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27).

Our novel RASP inhibitor reproxalap continues to progress toward New Drug... More